These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 12118339)
1. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH. Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339 [TBL] [Abstract][Full Text] [Related]
2. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. Chang SC; Lin JK; Lin TC; Liang WY Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene. Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735 [TBL] [Abstract][Full Text] [Related]
4. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma. Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227 [TBL] [Abstract][Full Text] [Related]
5. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283 [TBL] [Abstract][Full Text] [Related]
7. Mutations and allelic loss of p53 in primary tumor DNA from potentially cured patients with colorectal carcinoma. Forslund A; Lönnroth C; Andersson M; Brevinge H; Lundholm K J Clin Oncol; 2001 Jun; 19(11):2829-36. PubMed ID: 11387354 [TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms. Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212 [TBL] [Abstract][Full Text] [Related]
10. An abundance of p53 null mutations in ovarian carcinoma. Skilling JS; Sood A; Niemann T; Lager DJ; Buller RE Oncogene; 1996 Jul; 13(1):117-23. PubMed ID: 8700537 [TBL] [Abstract][Full Text] [Related]
11. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation. Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137 [TBL] [Abstract][Full Text] [Related]
12. Discordance of p53 mutations of synchronous colorectal carcinomas. Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269 [TBL] [Abstract][Full Text] [Related]
13. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection. Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240 [TBL] [Abstract][Full Text] [Related]
14. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Eguchi S; Kohara N; Komuta K; Kanematsu T Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566 [TBL] [Abstract][Full Text] [Related]
15. RER and LOH association with sporadic colorectal cancer in Taiwanese patients. Tsai MH; Yang YC; Chen KH; Jiang JK; Chou SJ; Chiang TC; Jan HS; Lou MA Hepatogastroenterology; 2002; 49(45):672-7. PubMed ID: 12063967 [TBL] [Abstract][Full Text] [Related]
16. Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Guldberg P; Nedergaard T; Nielsen HJ; Olsen AC; Ahrenkiel V; Zeuthen J Hum Mutat; 1997; 9(4):348-55. PubMed ID: 9101296 [TBL] [Abstract][Full Text] [Related]
17. Splicing mutations of the p53 gene in human hepatocellular carcinoma. Lai MY; Chang HC; Li HP; Ku CK; Chen PJ; Sheu JC; Huang GT; Lee PH; Chen DS Cancer Res; 1993 Apr; 53(7):1653-6. PubMed ID: 8384081 [TBL] [Abstract][Full Text] [Related]
18. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of genetic changes in progression of colorectal cancer]. Kuroda K; Watatani M; Yoshida T; Ieda S; Shindo K; Yasutomi M Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():164-8. PubMed ID: 8678562 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite analysis of fecal DNA for colorectal cancer detection. Koshiji M; Yonekura Y; Saito T; Yoshioka K J Surg Oncol; 2002 May; 80(1):34-40. PubMed ID: 11967905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]